- Home
- SIGA vs BVS Comparison
SIGA vs BVS Comparison
Compare SIGA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- BVS
- Stock Information
- Founded
- SIGA 1995
- BVS 2011
- Country
- SIGA United States
- BVS United States
- Employees
- SIGA N/A
- BVS N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SIGA Health Care
- BVS Health Care
- Exchange
- SIGA Nasdaq
- BVS Nasdaq
- Market Cap
- SIGA 515.1M
- BVS 448.8M
- IPO Year
- SIGA 1997
- BVS 2021
- Fundamental
- Price
- SIGA $8.28
- BVS $6.76
- Analyst Decision
- SIGA
- BVS Strong Buy
- Analyst Count
- SIGA 0
- BVS 4
- Target Price
- SIGA N/A
- BVS $13.75
- AVG Volume (30 Days)
- SIGA 479.2K
- BVS 305.6K
- Earning Date
- SIGA 11-06-2025
- BVS 11-04-2025
- Dividend Yield
- SIGA 7.11%
- BVS N/A
- EPS Growth
- SIGA N/A
- BVS N/A
- EPS
- SIGA 1.14
- BVS 0.03
- Revenue
- SIGA $179,639,422.00
- BVS $564,142,000.00
- Revenue This Year
- SIGA N/A
- BVS N/A
- Revenue Next Year
- SIGA $115.06
- BVS $6.88
- P/E Ratio
- SIGA $7.27
- BVS $245.20
- Revenue Growth
- SIGA 3.86
- BVS 5.08
- 52 Week Low
- SIGA $4.95
- BVS $5.81
- 52 Week High
- SIGA $9.62
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- SIGA 46.70
- BVS N/A
- Support Level
- SIGA $8.15
- BVS N/A
- Resistance Level
- SIGA $9.29
- BVS N/A
- Average True Range (ATR)
- SIGA 0.34
- BVS 0.00
- MACD
- SIGA -0.11
- BVS 0.00
- Stochastic Oscillator
- SIGA 24.62
- BVS 0.00
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.